MTOR and AL amyloidosis: As a dual inhibitor of PI3K and mTOR, NVP-BEZ235 has shown to induce autophagy in multiple myeloma cells (Ma et al., 2019), colorectal cancer cells (Oh et al., 2016), and esophageal cancer cells (Wu et al., 2018).